REFUAH LONGEVITY CENTER
Precise. Prescribed. Monitored.
Hormone and peptide care with labs before you begin and follow-up every step of the way.
Our standards
- FDA-approved medications first
- Compounded therapies only through licensed 503A/503B pharmacies, with current FDA bulk-substance status verified
- BPC-157, TB-500 and other FDA Category 2 substances are not offered
- Compounded GLP-1 medications are not offered by default
- Labs before treatment and again at 6–12 weeks
Consult: Inquire
Many peptides are not FDA-approved for the uses discussed online. Your physician will review evidence, risks and alternatives with you.
Formulary by category
| Category | Examples | Regulatory note |
|---|---|---|
| FDA-approved drugs | Semaglutide, tirzepatide (branded), testosterone, estradiol, progesterone | Approved indications, or off-label with documentation |
| Compounded (503A/503B) | Sermorelin, NAD+, glutathione, B12 blends | Eligibility changes; current FDA bulk-substance list confirmed |
| Excluded at launch | BPC-157, TB-500 and other FDA Category 2 peptides | Not offered unless counsel confirms a lawful pathway |
| Compounded GLP-1s | Not offered by default | Branded drugs preferred |
Prescribing and monitoring
- Physician prescription only after labs
- Licensed US pharmacies only
- Follow-up labs at 6–12 weeks
- Adverse-event reporting
- No shipping without a visit
Your next chapter starts with a conversation.
Come for the data. Stay for how you feel.
Educational content, not medical advice. Services follow physician evaluation, results vary, and some services are not FDA-approved for the uses described.